US 11535651
Hepatitis B nanoparticle-based vaccine for influenza virus
granted A61KA61K39/12A61K39/145
Quick answer
US patent 11535651 (Hepatitis B nanoparticle-based vaccine for influenza virus) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K39/12, A61K39/145, A61P, A61P31/16